NIH-funded research R21 grant

Understanding how specific proteins affect brain communication in autism

Official title: The identification and interrogation of novel intracellular proteins that underlie the distinct nanoscopic architecture of Neurexin-1 and Neurexin-3

Funded at University of Colorado Denver · NIH-11120279 · Data updated 2026-11-12

This study is looking at special proteins in the brain that help nerve cells talk to each other, and it aims to see how these proteins work differently in people with autism, which could help us understand autism better and find new ways to help.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Colorado Denver
NIH-funded
Lab location1 site (Aurora, UNITED STATES)
Project startApril 1, 2025
Project endMarch 31, 2027
Funding year2025
Award (this year)$422,280
NIH project number1R21MH140328-01
Project IDNIH-11120279 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with autism spectrum disorder.

Less likely to help

Patients without a diagnosis of autism spectrum disorder or those with unrelated neurological conditions may not benefit from this research.

What this research studies

This research investigates the unique structures of proteins called neurexins that play a crucial role in how brain cells communicate. By using advanced imaging techniques, the study aims to visualize how these proteins cluster and interact at synapses, which are the connections between nerve cells. The goal is to uncover the mechanisms behind their organization and how they may differ in individuals with autism spectrum disorder. This could lead to a better understanding of the biological basis of autism and potential new avenues for treatment.

Why it matters

Potential benefit: If successful, this research could provide insights that lead to improved therapies for individuals with autism spectrum disorder.

How similar studies have gone: Other research has shown promising results in understanding synaptic communication and its implications for autism, suggesting that this approach could yield valuable insights.

Where this research is happening

  • University of Colorado Denver
    Aurora, United States
    Active

Researchers

  • Principal investigator: Aoto, Jason — University of Colorado Denver
  • Study coordinator: Aoto, Jason

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.